Opportunity Information: Apply for RFA DA 23 015

The Transformative Research on the Basic Mechanisms of Polysubstance Use in Addiction (R01 - Clinical Trial Not Allowed) funding opportunity, identified as RFA-DA-23-015, is a discretionary NIH grant program focused on advancing fundamental, mechanistic knowledge about why and how people use multiple substances in the context of addiction. The central goal is to fund research that can meaningfully shift or expand current scientific understanding of polysubstance use, rather than simply describing patterns of use. The emphasis is on hypothesis-driven work that digs into underlying mechanisms and produces insights that could reshape how the field conceptualizes polysubstance addiction.

This FOA supports exploratory but mechanistic projects that investigate polysubstance use across a wide range of possible levels of analysis. Proposed studies can focus on behavioral and cognitive processes (such as decision-making, reinforcement learning, impulsivity, stress responding, habit formation, or cue reactivity), as well as biological and neurobiological mechanisms. On the biological side, applicants may examine cellular and molecular processes, neural circuits and systems-level brain function, and genetic or epigenetic contributors that influence vulnerability, progression, or persistence of polysubstance use. The FOA also allows pharmacological approaches, which can include work on how different drugs interact within the body or brain and how those interactions may alter reward, withdrawal, tolerance, or toxicity mechanisms. Computational approaches are also explicitly encouraged, which could include modeling of multi-drug reinforcement dynamics, prediction of transitions between single-substance and polysubstance use, or integrative analyses that combine behavioral, biological, and environmental data to identify mechanisms and test causal hypotheses.

A key boundary is that this is an R01 mechanism with a "Clinical Trial Not Allowed" designation, meaning the program is not intended to support clinical trials that prospectively assign human participants to interventions to evaluate health-related outcomes. In practice, that generally steers applications toward basic and translational mechanistic research rather than intervention efficacy testing. Investigators can still consider human-focused mechanistic work when it fits NIH rules for non-trial research (for example, observational studies or laboratory-based assessments that do not meet the NIH definition of a clinical trial), but proposals should be carefully structured to remain outside clinical trial scope.

The opportunity falls under the NIH funding activity category of Education and Health and is associated with CFDA number 93.279. The program is offered as a grant, and the listed award ceiling is $350,000. The original closing date for the opportunity was November 14, 2022, and the FOA record was created on June 2, 2022.

Eligibility is broad and includes a wide range of public and private organizations. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and additional entities categorized as "Others." The FOA also explicitly highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, non-domestic (non-U.S.) entities including foreign organizations, regional organizations, tribal governments other than federally recognized entities, and U.S. territories or possessions. This wide eligibility signals an intent to encourage participation from diverse institutions and communities, including those with strong connections to populations disproportionately affected by substance use and related harms.

Overall, the grant is designed for researchers proposing rigorous, mechanism-centered studies that can clarify the interacting drivers of polysubstance use and addiction, whether those drivers are rooted in brain circuitry, molecular adaptations, genetic and epigenetic regulation, cognitive and behavioral processes, drug-drug interactions, or computationally modeled systems. The most competitive projects under this FOA would typically be expected to articulate a clear mechanistic hypothesis, use methods capable of testing causal or explanatory pathways (not just correlations), and show how the findings could transform the scientific picture of polysubstance use rather than incrementally adding to it.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2022-06-02.
  • Applicants must submit their applications by 2022-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $350,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 23 015

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)

Previous opportunity: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 23 015

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 23 015) also looked into and applied for these:

Funding Opportunity
Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 181

Funding Number: PAR 22 181
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 23 020

Funding Number: RFA DA 23 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 23 019

Funding Number: RFA DA 23 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 22 165

Funding Number: PAR 22 165
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 22 164

Funding Number: PAR 22 164
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Apply for PAR 22 198

Funding Number: PAR 22 198
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 026

Funding Number: RFA CA 22 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $5,500,000
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Apply for PAR 22 199

Funding Number: PAR 22 199
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 052

Funding Number: RFA DA 23 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional) Apply for RFA DA 23 011

Funding Number: RFA DA 23 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Apply for PAR 22 173

Funding Number: PAR 22 173
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Apply for PAR 22 174

Funding Number: PAR 22 174
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed) Apply for RFA DA 23 017

Funding Number: RFA DA 23 017
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 22 201

Funding Number: PAR 22 201
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only) Apply for RFA DA 23 018

Funding Number: RFA DA 23 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,500,000
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional) Apply for RFA DA 23 046

Funding Number: RFA DA 23 046
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed) Apply for RFA DA 23 045

Funding Number: RFA DA 23 045
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed) Apply for RFA NS 23 014

Funding Number: RFA NS 23 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) Apply for PAR 22 203

Funding Number: PAR 22 203
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,200,000
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional) Apply for RFA DA 23 051

Funding Number: RFA DA 23 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 015", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: